CTH Promotes Liver Cancer Progression and Exploratory Evaluation Supports Enhanced Antitumor Activity of PPG Plus GPC3 CAR‐T Cells
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/3351382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Yuxin Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Scienc…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Cystathionine gamma-Lyase, Glycine. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Although hydrogen sulfide (H 2 S) is a key regulator in cancer biology, the mechanism by which the H 2 S‐producing enzyme cystathionine‐γ‐lyase (CTH) functions in hepatocellular carcinoma (HCC) remains elusive. Using the slow‐releasing H 2 S donor GYY4137, we observed enhanced migration and invasion in HuH7 and HepG2 cells. Subsequently, we observed consistent protumorigenic effects of CTH not only in vitro but also in subcutaneous and orthotopic mouse models. Here, our findings suggest that CTH‐H 2 S sulfhydrates Rab7a, which may be associated with HCC progression. We further showed that CTH modulates the expression of autophagy‐related proteins in liver tumor cells. In nude mouse subcutaneous xenograft experiments, compared with the vehicle group, the combination of DL‐propargylglycine (PPG, CTH inhibitor) and GPC3 CAR‐T exhibited better antitumor efficacy compared to PPG or CAR‐T alone. Our findings suggest that CTH modulation was associated with altered Rab7a sulfhydration and autophagy and that combined PPG and GPC3 CAR‐T therapy exerts better antitumor efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100005, China, cacms.ac.…
- Department of Interventional Radiology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, China, qdu.edu.cn.
ORCID-Profile: Yuxin Guo, Man Yu, Xilin Zhu, Wei Li, Ying Liu, Xiaopan Wu
Förderung
- CAMS Innovation Fund for Medical Sciences of China
- National Key Research and Development Program of China
Zitieren
APA
Guo, Y., Yu, M., Zhu, X., Li, W., Liu, Y., & Wu, X. (2026). CTH Promotes Liver Cancer Progression and Exploratory Evaluation Supports Enhanced Antitumor Activity of PPG Plus GPC3 CAR‐T Cells. Journal of Immunology Research. https://doi.org/10.1155/jimr/3351382
Vancouver
Guo Y, Yu M, Zhu X, Li W, Liu Y, Wu X. CTH Promotes Liver Cancer Progression and Exploratory Evaluation Supports Enhanced Antitumor Activity of PPG Plus GPC3 CAR‐T Cells. Journal of Immunology Research. 2026. doi:10.1155/jimr/3351382
BibTeX
@article{Guo2026,
author = {Guo, Yuxin and Yu, Man and Zhu, Xilin and Li, Wei and Liu, Ying and Wu, Xiaopan},
title = {CTH Promotes Liver Cancer Progression and Exploratory Evaluation Supports Enhanced Antitumor Activity of PPG Plus GPC3 CAR‐T Cells},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/3351382}
}
EUVIMED